A Study of TAK-500 With or Without Pembrolizumab in Adults With Select Locally Advanced or Metastatic Solid Tumors
Takeda
Takeda
Intensity Therapeutics, Inc.
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
VA Office of Research and Development
Pfizer
National Institutes of Health Clinical Center (CC)
Masonic Cancer Center, University of Minnesota
Curis, Inc.